Andrew J Woolley, PhD

I've accepted a role at Bristol Myers Squibb in Redwood City, CA, the site where important Immuno-Oncology drugs Opdivo and Yervoy were originally developed.  I will be helping to lead the Histopathology group as a Principal Scientist in Translational Research, focusing on digital pathology and multiplex immunohistochemistry technologies to deeply characterize cancer tissues.

I accepted a position at AbbVie Biotherapeutics in Redwood City, CA.  Excited to start this new role as Senior Scientist focusing on Translational Histopathology, adding my fancy bio-imaging and image analysis skills to their stellar immune-oncology team.

Symic Bio's website is now sharing the 'mechanism-of-action' video I helped to develop for compound 'SB-030'.  - www.symic.bio/pipeline/vascular-disease/. Including two stills below.
​

I contacted a number of scientific computer-animation groups, and ended up going with XVIVO, who are wonderful.  - ​www.xvivo.net

Gianni Amato, Senior Director of Marketing and Business Analytics at Symic Bio, did all of the heavy lifting to see this project through, but I really enjoyed getting it rolling and helping where I could, and am very happy with the final result.  As a nice gesture, XVIVO sent over a printed still from the video, seen below.

Sharing more 'selfie' images of the microscopy art prints hanging up at Symic Bio HQ.  This imaging data was collected by myself in support of studies at Symic Bio, and printed to have something interested on the otherwise bare walls.

Cell culture on a coated surface

Lung tissue histology

Channels of a microfluidic assay

ELISA whole plate image - (intentionally wanted ones that were not just tissue or cells)

Lung tissue section

Showed large microscopy art prints at the UC Berkeley 'Vision+Light' event, held in the Li Ka Shing Center for Biomedical and Health Sciences atrium.  Very cool event!  So much science-inspired artwork.  Many thanks to microscopy facility director Dr. Holly Aarons for sharing the connection!